Galectin Therapeutics Inc. - Units

YTD

ALL

Why Robinhood?

You can watch GALTU and buy or sell other stocks, ETFs, and their options commission-free!

About GALTU

Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs target the development of carbohydrate molecules which offers alternative options to larger market segments.

CEO

Joel Lewis, CPA

CEOJoel Lewis, CPA

Employees

—

Employees—

Headquarters

Norcross, Georgia

HeadquartersNorcross, Georgia

Founded

2000

Founded2000

Employees

—

Employees—

GALTU Key Statistics

Market cap

—

Market cap—

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

1.45K

Average volume1.45K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$19.20

52 Week high$19.20

52 Week low

$1.13

52 Week low$1.13

Stock Snapshot

Galectin Therapeutics Inc. - Units(GALTU) stock is priced at $4.10.

Galectin Therapeutics Inc. - Units(GALTU) stock opened on 2025-12-14 at —. The price climbed to — and dipped to —.

Galectin Therapeutics Inc. - Units(GALTU) shares are trading with a volume of 0, against a daily average of 1.45K.

During the past year, Galectin Therapeutics Inc. - Units(GALTU) stock moved between $1.13 at its lowest and $19.20 at its peak.